Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Reply to technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
Guebeli N, Warschkow R, Ackermann C, Schmied B, Cerny T, ess s. Reply to technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection. Swiss Med Wkly 2018; 148:w14583.
29.01.2018Reply to technical comment on: Güller et al. Lower hospital volume is associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer resection
29.01.2018Swiss Med Wkly 2018; 148:w14583
Guebeli Nadia, Warschkow Rene, Ackermann Christoph Jakob, Schmied Bruno, Cerny Thomas, ess silvia
Immune checkpoint inhibitors and small cell lung cancer: what’s new?
Schmid S, Früh M. Immune checkpoint inhibitors and small cell lung cancer: what’s new?. Journal of theoracic disease 2018; 10:1503-1508.
14.01.2018Immune checkpoint inhibitors and small cell lung cancer: what’s new?
14.01.2018Journal of theoracic disease 2018; 10:1503-1508
Schmid Sabine, Früh Martin
Hypotension due to spinal anesthesia influences fetal circulation in primary caesarean sections
Lato K, Bekes I, Widschwendter P, Friedl T, Janni W, Reister F, Froeba G, Friebe-Hoffmann U. Hypotension due to spinal anesthesia influences fetal circulation in primary caesarean sections. Arch Gynecol Obstet 2018; 297:667-674.
12.01.2018Hypotension due to spinal anesthesia influences fetal circulation in primary caesarean sections
12.01.2018Arch Gynecol Obstet 2018; 297:667-674
Lato K, Bekes Inga, Widschwendter Peter, Friedl T W P, Janni W, Reister F, Froeba G, Friebe-Hoffmann U
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
Hottinger A, Bodmer A, Weber D, Schaller K, Mach N, Hundsberger T, Vargas M, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P. Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma. Br J Cancer 2018
09.01.2018Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
09.01.2018Br J Cancer 2018
Hottinger A F, Bodmer A, Weber D C, Schaller K, Mach N, Hundsberger Thomas, Vargas M I, Dunkel N, Squiban D, Espeli V, Ben Aissa A, Dietrich P-Y
Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness
Bösch M, Knauer M, Ruhstaller T, Jochum W, Gastl G, Sopper S, Mörbe U, Novkovic M, Cheng H, Onder L, Ludewig B. Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness. Oncoimmunology 2018; 7:e1414129.
03.01.2018Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness
03.01.2018Oncoimmunology 2018; 7:e1414129
Bösch Maximilian, Knauer Michael, Ruhstaller Thomas, Jochum Wolfram, Gastl Guenther, Sopper Sieghart, Mörbe Urs, Novkovic Mario, Cheng Hung-Wei, Onder Lucas, Ludewig Burkhard
Verbesserte Wirksamkeit von Proteasom-Inhibitoren in der Behandlung des Nierenzellkarzinoms durch die Kombination mit den HIV-Protease-Inhibitoren Lopinavir und Nelfinavir
Abt D, Driessen C, Engeler D, Schmid H, Slaby O, Vodinska M, Silzle T, Bader J, Kraus M, Sedlarikova L, Besse A, Besse L. Verbesserte Wirksamkeit von Proteasom-Inhibitoren in der Behandlung des Nierenzellkarzinoms durch die Kombination mit den HIV-Protease-Inhibitoren Lopinavir und Nelfinavir. German Medicale Science, www.egms.de 2018
01.01.2018Verbesserte Wirksamkeit von Proteasom-Inhibitoren in der Behandlung des Nierenzellkarzinoms durch die Kombination mit den HIV-Protease-Inhibitoren Lopinavir und Nelfinavir
01.01.2018German Medicale Science, www.egms.de 2018
Abt Dominik, Driessen Christoph, Engeler Daniel, Schmid Hans-Peter, Slaby O, Vodinska M, Silzle T, Bader J, Kraus M, Sedlarikova L, Besse A, Besse L
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir
Abt D, Driessen C, Engeler D, Schmid H, Slaby O, Vodinska M, Silzle T, Bader J, Kraus M, Sedlarikova L, Besse A, Besse L. Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir. BJU Int 2018; 121:600-9.
01.01.2018Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir
01.01.2018BJU Int 2018; 121:600-9
Abt Dominik, Driessen Christoph, Engeler Daniel, Schmid Hans-Peter, Slaby O, Vodinska M, Silzle T, Bader J, Kraus M, Sedlarikova L, Besse A, Besse L
Behandlung des fortgeschrittenen Prostatakarzinoms - eine interdisziplinäre Empfehlung
Omlin A, Zwahlen D, Wyler S, Wild D, Templeton A, Stenner F, Schmid H, Roggero E, Rentsch C, Nitzsche E, Kueng M, Jochum W, Gillessen Sommer S, Eberli D, Beyer J, Spahn M, Cathomas R. Behandlung des fortgeschrittenen Prostatakarzinoms - eine interdisziplinäre Empfehlung. Schweiz Rundschau Med (PRAXIS) 2018; 107:1043-51.
01.01.2018Behandlung des fortgeschrittenen Prostatakarzinoms - eine interdisziplinäre Empfehlung
01.01.2018Schweiz Rundschau Med (PRAXIS) 2018; 107:1043-51
Omlin Aurelius, Zwahlen D, Wyler S, Wild D, Templeton Arnoud, Stenner F, Schmid Hans-Peter, Roggero E, Rentsch CA, Nitzsche E, Kueng M, Jochum W, Gillessen Sommer Silke, Eberli D, Beyer J, Spahn M, Cathomas R
Prostatakarzinom im Alter. Diagnostik und Therapie bei Betagten
Viktorin P, Omlin A, Schmid H. Prostatakarzinom im Alter. Diagnostik und Therapie bei Betagten. info@onkologie 2018; 8:5-8.
01.01.2018Prostatakarzinom im Alter. Diagnostik und Therapie bei Betagten
01.01.2018info@onkologie 2018; 8:5-8
Viktorin P, Omlin Aurelius, Schmid Hans-Peter
Influence of Prognostic Factors on Lymph Node Involvement in Endometrial Cancer: A Single-Center Experience
Widschwendter P, Bauer E, De Gregorio N, Bekes I, Janni W, Scholz C, Friedl T. Influence of Prognostic Factors on Lymph Node Involvement in Endometrial Cancer: A Single-Center Experience. Int J Gynecol Cancer 2018; 28:1145-1152.
01.01.2018Influence of Prognostic Factors on Lymph Node Involvement in Endometrial Cancer: A Single-Center Experience
01.01.2018Int J Gynecol Cancer 2018; 28:1145-1152
Widschwendter Peter, Bauer Emanuel, De Gregorio Nikolaus, Bekes Inga, Janni Wolfgang, Scholz Christoph, Friedl Thomas W P
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
Möbus V, Kurbacher C, Untch M, Konecny G, Hinke A, Runnebaum I, von Minckwitz G, Harbeck N, Huober J, Schneeweiss A, Nitz U, Kuhn W, Thomssen C, du Bois A, Lück H, Jackisch C, AGO Breast Study Group (AGO-B). Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial. Ann Oncol 2018; 29:178-185.
01.01.2018Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
01.01.2018Ann Oncol 2018; 29:178-185
Möbus V, Kurbacher C, Untch M, Konecny G E, Hinke A, Runnebaum I B, von Minckwitz G, Harbeck N, Huober Jens, Schneeweiss A, Nitz U, Kuhn W, Thomssen C, du Bois A, Lück H J, Jackisch C, AGO Breast Study Group (AGO-B)
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
Balmelli C, Stenner F, Pless M, Weidner S, Zimmermann S, Güthner C, Cristina V, Cathomas R, Feuerlein K, Siano M, Railic N, Rothschild S. Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program. J Cancer 2018; 9:250-255.
01.01.2018Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
01.01.2018J Cancer 2018; 9:250-255
Balmelli Catharina, Stenner Frank, Pless Miklos, Weidner Sabine, Zimmermann Stefan, Güthner Christiane, Cristina Valerie, Cathomas Richard, Feuerlein Kristin, Siano Marco, Railic Nikola, Rothschild Sacha I
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
Ponde N, Maetens M, Harbeck N, Pusztai L, Berghorn M, Im Y, Borrego M, Chen D, Rodeheffer R, Piccart M, Suter T, Bozovic-Spasojevic I, Fumagalli D, Bradbury I, Lambertini M, Ewer M, Campbell C, Ameels H, Zardavas D, Di Cosimo S, Baselga J, Huober J, Izquierdo M, de Azambuja E. Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). Breast Cancer Res Treat 2017; 168:631-638.
27.12.2017Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06)
27.12.2017Breast Cancer Res Treat 2017; 168:631-638
Ponde Noam, Maetens Marion, Harbeck Nadia, Pusztai Lajos, Berghorn Michael, Im Young-Hyuck, Borrego Manuel Ruiz, Chen Dar-Ren, Rodeheffer Richard, Piccart Martine, Suter Thomas, Bozovic-Spasojevic Ivana, Fumagalli Debora, Bradbury Ian, Lambertini Matteo, Ewer Michael, Campbell Christine, Ameels Helene, Zardavas Dimitrios, Di Cosimo Serena, Baselga José, Huober Jens, Izquierdo Miguel, de Azambuja Evandro
Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
Ludwig H, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk N, Waage A, Beksac M, Mellqvist U, Engelhardt M, Caers J, Driessen C, Mateos M, Garderet L, Zweegman S, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos M, San-Miguel J, Terpos E, Sonneveld P. Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network. Leukemia 2017
18.12.2017Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network
18.12.2017Leukemia 2017
Ludwig H, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk N W C J, Waage A, Beksac M, Mellqvist U H, Engelhardt M, Caers J, Driessen Christoph, Mateos M-V, Garderet L, Zweegman S, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M, Hajek R, Mohty M, Cavo M, Dimopoulos M A, San-Miguel J F, Terpos E, Sonneveld P
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?
Polasik A, Janni W, Huober J, Müller V, Schneeweiss A, Fasching P, Hartkopf A, Rack B, Friedl T, De Gregorio A, Schochter F, Tzschaschel M, Fehm T. Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?. Geburtshilfe Frauenheilkd 2017; 77:1291-1298.
18.12.2017Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?
18.12.2017Geburtshilfe Frauenheilkd 2017; 77:1291-1298
Polasik Arkadius, Janni Wolfgang, Huober Jens, Müller Volkmar, Schneeweiss Andreas, Fasching Peter A, Hartkopf Andreas, Rack Brigitte, Friedl Thomas W P, De Gregorio Amelie, Schochter Fabienne, Tzschaschel Marie, Fehm Tanja
Update Breast Cancer 2017 - Implementation of Novel Therapies
Lux M, Wallwiener M, Müller V, Beckmann M, Belleville E, Fehm T, Wallwiener D, Brucker S, Schneeweiss A, Luftner D, Huober J, Ettl J, Janni W, Hartkopf A, Nabieva N, Taran F, Overkamp F, Kolberg H, Hadji P, Tesch H, Fasching P. Update Breast Cancer 2017 - Implementation of Novel Therapies. Geburtshilfe Frauenheilkd 2017; 77:1281-1290.
18.12.2017Update Breast Cancer 2017 - Implementation of Novel Therapies
18.12.2017Geburtshilfe Frauenheilkd 2017; 77:1281-1290
Lux Michael P, Wallwiener Markus, Müller Volkmar, Beckmann Matthias W, Belleville Erik, Fehm Tanja N, Wallwiener Diethelm, Brucker Sara Y, Schneeweiss Andreas, Luftner Diana, Huober Jens, Ettl Johannes, Janni Wolfgang, Hartkopf Andreas D, Nabieva Naiba, Taran Florin-Andrei, Overkamp Friedrich, Kolberg Hans-Christian, Hadji Peyman, Tesch Hans, Fasching Peter A
Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient
Hundsberger T. Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient. Austin J Neurol Disord Epilepsy 2017; 4:1036.
08.12.2017Herpes zoster induced predominant motor lumbal plexopathy in a lung cancer patient
08.12.2017Austin J Neurol Disord Epilepsy 2017; 4:1036
Hundsberger Thomas
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
Di Cosimo S, Ng W, Colleoni M, Ferro A, Naume B, Patel A, Huober J, Piccart-Gebhart M, Baselga J, Vinholes J, Fein L, Fumagalli D, Campbell C, Azim H, Galli G, Bregni G, Curigliano G, Criscitiello C, Izquierdo M, de la Pena L, De Azambuja E. The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. Eur J Cancer 2017; 89:42-48.
08.12.2017The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
08.12.2017Eur J Cancer 2017; 89:42-48
Di Cosimo S, Ng W M J, Colleoni M, Ferro A, Naume B J, Patel A, Huober Jens, Piccart-Gebhart M J, Baselga J, Vinholes J, Fein L, Fumagalli D, Campbell C, Azim H A, Galli G, Bregni G, Curigliano G, Criscitiello C, Izquierdo M, de la Pena L, De Azambuja E
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial
Gennari A, Bernhard J, Morales S, Pagani O, Barbeaux A, Borstnar S, Rabaglio-Poretti M, Maibach R, Regan M, Ribi K, Amillano Parraga K, Walshe J, Sun Z, Hasler-Strub U, Colleoni M, Kennedy M, von Moos R, Cortes J, Vidal M, Hennessy B, Jerusalem G. A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. Ann Oncol 2017
08.12.2017A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial
08.12.2017Ann Oncol 2017
Gennari A, Bernhard J, Morales S Murillo, Pagani O, Barbeaux A, Borstnar S, Rabaglio-Poretti M, Maibach R, Regan M M, Ribi K, Amillano Parraga K, Walshe J, Sun Z, Hasler-Strub Ursula, Colleoni M, Kennedy M J, von Moos R, Cortes J, Vidal M J, Hennessy B, Jerusalem G
Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013
Schnegg-Kaufmann A, Bonadies N, Arndt V, Stussi G, Passweg J, Chalandon Y, Spertini O, Hess U, Bargetzi M, Efthymiou A, Gregor M, Manz M, Rovó A, Baldomero H, Feller A, NICER Working Group. Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. Cancer Epidemiol 2017; 52:55-62.
07.12.2017Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013
07.12.2017Cancer Epidemiol 2017; 52:55-62
Schnegg-Kaufmann Annatina, Bonadies Nicolas, Arndt Volker, Stussi Georg, Passweg Jakob R, Chalandon Yves, Spertini Olivier, Hess Urs, Bargetzi Mario, Efthymiou Anna, Gregor Michael, Manz Markus G, Rovó Alicia, Baldomero Helen, Feller Anita, NICER Working Group